Research
Independent analysis of SEC filings, private funds, RIAs, websites and regulatory records.
LuminArx Opportunistic Alternative Solutions SEC Form D Review 2026: $172.3M Onshore Fund Inside a $4.5B Capital Solutions Platform
LuminArx Opportunistic Alternative Solutions Onshore Fund LP is one of the stronger manager-verification cases in this A-list because the fund can be followed through several independent regulatory layers rather than only through a Form D. The Delaware partnership was formed in 2023 and its latest publicly available amendment reports $172,316,000 sold to 27 investors, an indefinite offering, a September 12, 2023 first sale, Rule 506(b) and Investment Company Act Section 3(c)(7). LuminArx Capital Fund GP LP is identified as general partner, while co-founders Min Htoo and Gideon Berger are disclosed through the general-partner control chain. The issuer uses the same 712 Fifth Avenue, 23rd Floor New York address as LuminArx Capital Management LP, which is independently registered with the SEC under CRD 327065 and file number 801-128287. This alignment among fund, GP, founders, adviser, address and regulatory identifiers creates a substantially stronger identity chain than is available for many newly formed private funds.
LuminArx Opportunistic Alternative Solutions Onshore Fund LP · CIK 0001991606Read article →
CG Core Value Fund SEC Review 2026: $118.4M Circumference Group Fund, RGP Board Engagement and an Operator-Led Value Strategy
CG Core Value Fund is the long-running public-markets investment vehicle of Little Rock-based Circumference Group, not a newly formed generic value fund. The September 1, 2026 Form D/A reports $118.4 million cumulatively sold to 58 investors, including four non-accredited investors, with a $500,000 minimum, an indefinite Rule 506(b) offering and reliance on Section 3(c)(1). The amount sold is unchanged from the 2025 amendment, so there was no additional Form D capital reported during the latest filing year. The fund's history reaches back much further: its first sale occurred in October 2011 and its previous legal name was CG Tech/Telecom Equity Value Fund LP, which fits Circumference Group's historical concentration in technology, telecommunications and operationally complex businesses. The manager, The Circumference Group LLC, is a fully SEC-registered adviser under CRD 159012 / SEC 801-113735 and reported approximately $239.6 million of regulatory assets in its March 2026 Form ADV. The fund's distinctive feature is not simply low-multiple stock selection; Circumference uses an operator-led framework called the Core Value Assessment to identify companies where strategic complexity, operational problems or market impatience may create a gap between quoted price and sustainable long-term business value.
CG Core Value Fund, L.P. · CIK 0001579867Read article →
Harvey AI SEC Form D Review: $550.3M Sold at a $15.5B Valuation as Legal AI Moves Beyond OpenAI
Harvey AI Corp's September 2026 Form D provides a more precise picture of its latest financing than the round-number headlines. The Delaware corporation reports an indefinite Rule 506(b) equity offering, a first sale on August 28, 2026 and exactly $550,299,446 sold to 28 investors. The filing reports no sales commissions or finder fees, a $0 minimum investment and no planned payments of offering proceeds to the listed related persons. Harvey declined to disclose its revenue range. Three days earlier in practical fundraising terms, the company announced what it described as a $550 million round at a $15.5 billion valuation, co-led by Diffusion and Lightspeed Venture Partners, with participation from existing investors including Sequoia, Kleiner Perkins, Andreessen Horowitz, Coatue, Conviction, Elad Gil, Evantic, GIC, Goldman Sachs Alternatives, Verified Capital and WNDR, plus new investors including Sapphire Ventures and Whale Rock. The SEC and company disclosures are therefore consistent at the headline level, but investors should preserve the distinction between the SEC's exact amount sold, the company's rounded financing announcement and the private valuation assigned to the company.
Harvey AI SEC · CIK 0001974654Read article →
Boldcap Fund III SEC Review 2026: $7M Raised for an AI-Native Seed Fund Backing Frontier Technical Founders
Boldcap Fund III LP is the newest U.S. venture vehicle of BoldCap, an early-stage investment platform founded around Indian-origin technical founders building globally oriented software businesses. The September 1, 2026 Form D reports $7 million sold to seven investors only about four weeks after the August 4 first sale, with an indefinite Rule 506(b) offering and Section 3(c)(7) status. Boldcap Fund III GP LLC is the general partner, while Sathyanarayanaa Nellore Sampat and Ravi Arumbakam are each identified as managing members of the GP; Ravi Arumbakam signed the filing. The SEC form reports a $0 minimum investment, which should not be confused with BoldCap's public statement that it typically invests roughly $250,000 to $1 million into portfolio companies. The latter describes the venture fund's outgoing check size, not the minimum commitment required from an LP.
Boldcap Fund III LP · CIK 0002148753Read article →
Arroyo Investors Fund V SEC Form D Review: $0-Sold Launch After a $1B+ Fund IV Energy Infrastructure Close
Arroyo Investors Fund V, L.P. entered the SEC record on September 16, 2026, but the filing does not establish that the fifth flagship fund has already raised capital. The Delaware limited partnership classified itself as a private equity fund, elected Section 3(c)(7), and relied on Rule 506(c) rather than the more common private-fund Rule 506(b) route. Its offering amount is "Indefinite," the amount sold is $0, the investor count is zero, and the filing explicitly says the first sale has yet to occur. That combination makes Fund V a fundraising-launch filing rather than a fundraising-result filing. It also means there is no SEC-disclosed Fund V target that can responsibly be converted into a headline such as "$1 billion Fund V" unless Arroyo later announces a target or subsequent filing supplies one. The fund is intended to remain open for more than one year and reports a $0 regulatory minimum, but actual institutional subscription minimums may be established in the limited partnership agreement or negotiated side letters.
Arroyo Investors Fund V, L.P. · CIK 0002147350Read article →
CrossHarbor Institutional Partners XI SEC Review 2026: New Opportunity Fund Launch From an $11.3B Real Estate Platform
CrossHarbor Institutional Partners XI LP is the newest generation of CrossHarbor Capital Partners' flagship opportunistic real estate fund series, but the SEC record currently supports a pre-investment-period conclusion rather than a fundraising-success story. The main Fund XI vehicle was formed in Delaware in 2026 and filed its first Form D on April 2, reporting an indefinite Rule 506(b) offering with first sale yet to occur, $0 sold and zero investors. CIP XI GP LP is the general partner, CrossHarbor Capital Partners LLC is the general partner of that GP and Jay C. Hart signed the filing as Managing Partner. Additional Fund XI structures have already appeared, including CrossHarbor Institutional Partners (Parallel) XI LP in August and CrossHarbor Institutional Partners (CMA) XI LP in September; both were also filed as new Rule 506(b) vehicles with first sale yet to occur and $0 sold. These entities should therefore be treated as one Fund XI architecture rather than three separate brands, and current public filings should not be used to claim that CrossHarbor has already raised a specific amount for Fund XI.
CrossHarbor Institutional Partners XI LP · CIK 0002123447Read article →
Tempo Therapeutics SEC Form D Review: $14.5M Financing After TT101 First-in-Human Results and FDA De Novo Submission
Tempo Therapeutics' September 2026 financing sits at an unusually important transition point in the company's development. The September 11 Form D identifies Tempo Therapeutics, Inc. as a Delaware biotechnology corporation operating from 3030 Bunker Hill Street in San Diego and reports a $14.5 million Rule 506(b) debt offering. The filing states that the first sale occurred August 27, 2026 and that $14 million had already been sold to 43 investors, leaving only $500,000 remaining. It reports no sales commissions, no finder fees and no proposed payments from proceeds to the listed officers or directors. Five days later, Tempo publicly announced that the financing had closed oversubscribed at the full $14.5 million. That chronology is important: the SEC filing captures the round shortly before final close, while the company's later announcement explains the final $500,000 difference. Investors should also note that this is debt financing, not another Series A-style equity raise, so the economics cannot be evaluated properly without reviewing maturity, interest, conversion, security, covenants or other debt terms that Form D does not disclose.
Tempo Therapeutics, Inc. · CIK 0001813688Read article →
Four Cities Fund V SEC Form D Review 2026: Why a $5.435M Venture Fund Now Reports $0 Sold
Four Cities Fund V, LP is a real Delaware venture capital partnership with a regulatory trail that can be tied to the Four Cities Capital investment platform, but its SEC history contains an unusually important reporting change. The fund was formed in 2021 and its original October 8, 2021 Form D identified Four Cities Fund GP, LLC as general partner, Matthew McKnight and Louis Beryl as managers of the general partner, classified the issuer as a venture capital fund and reported a September 28, 2021 first sale. That filing disclosed an indefinite offering, $5,435,000 already sold, 21 investors and a $10,000 minimum investment while relying on Rule 506(b) and Investment Company Act Section 3(c)(1). By contrast, the April 2025 amendment and the September 18, 2026 amendment report $0 sold, zero investors and a $0 stated minimum while shifting the Investment Company Act exclusion to Section 3(c)(7). The latest amendment still preserves the original September 28, 2021 first-sale date. This makes the filing history itself the central diligence issue: a $0 amount on the newest amendment should not automatically be interpreted as a current NAV of zero, a total loss, or evidence that every investor exited, because Form D is an offering notice rather than a complete capital-account statement.
Four Cities Fund V, LP · CIK 0001883156Read article →
UV Labs AI SEC Form D Review: $35K Raised Behind a Financial-AI Platform Claiming $375M+ in Live Trading Volume
UV Labs AI, Inc. filed its first visible Form D in September 2026, and the regulatory numbers are modest compared with the operating scale presented on the company's own website. The Delaware corporation reported a $5 million offering under Rule 506(b), with a first sale dated September 1, 2026. At filing, only $35,000 had been sold to two investors, leaving $4.965 million remaining. The securities include equity, options or warrants and securities issuable upon exercise of those rights. The minimum outside investment is $10,000, sales commissions and finder fees are reported at zero, and no offering proceeds were reported as planned payments to listed related persons. UV Labs declined to disclose its revenue range. Those facts matter because a visitor seeing a $5 million headline should not describe UV Labs as having "raised $5 million"; the SEC filing shows that approximately 0.7% of the stated offering had been sold when the notice was submitted.
UV Labs AI, Inc. · CIK 0002155383Read article →
9823 Fund SEC Review 2026: $126M Hedge Fund, White Star Rebrand and a Systematic Fundamental Strategy
9823 Fund LP is not a newly created hedge fund with no history. It is the renamed successor to White Star Fund LP and sits inside a Dallas investment platform that traces its legal and operating roots back more than two decades. The September 4, 2026 Form D/A reports $125,952,000 cumulatively sold to 24 investors, a $500,000 minimum, an indefinite Rule 506(b) offering and reliance on Section 3(c)(1). Dana Blair Baker is the controlling investment figure, while 9823 Capital LP serves as adviser and management entity and Nick Roossien signs the fund's SEC filings as CFO and CCO of the general partner. SEC IAPD identifies 9823 Capital as the renamed successor to White Star Capital and shows the firm as fully SEC registered under CRD 324329 / SEC 801-127155. The official website independently explains that the "9823" name reflects a strategy evolution from an investment firm founded in the late 1990s into a technology-heavy systematic platform relaunched under the new branding in 2023.
9823 Fund, L.P. · CIK 0001955969Read article →
RB Capital Partners SPV LLC SEC Form D Review 2026: $14.77M Slewgrass Fund and the Critical Same-Name Distinction
RB Capital Partners SPV LLC is not simply another anonymous "RB Capital" entity. The Delaware LLC has maintained a continuous SEC Form D trail since 2021 and the September 18, 2026 amendment directly links the vehicle to Slewgrass Partners LLC, Slewgrass Capital, LLC and George Douglas Dillard. The filing identifies Slewgrass Partners as managing member of the issuer, Slewgrass Capital as managing member of Slewgrass Partners, and Dillard as manager of Slewgrass Capital, creating a three-level control chain visible inside the SEC record itself. The vehicle relies on Regulation D Rule 506(b) and Investment Company Act Section 3(c)(1), offers pooled investment fund interests for an indefinite amount and reports $14,765,346 sold to 16 investors. Its first sale occurred on June 29, 2021, so the 2026 filing represents roughly five years of operating history rather than the launch of a new fund. The filing nevertheless declines to disclose aggregate NAV and reports a $0 minimum investment, meaning public Form D data are useful for tracing capital formation and ownership but insufficient for determining current fund value, subscription eligibility or investor economics. :contentReference[oaicite:0]{index=0}
RB Capital Partners SPV LLC · CIK 0001868515Read article →
Concentric Capital Strategies Fund SEC Review 2026: $33.7M Domestic Feeder Inside a $3.1B Long/Short Platform
Concentric Capital Strategies Fund LP is a domestic feeder within a much larger long/short hedge-fund platform managed by SEC-registered Concentric Capital Strategies L.P.; it should not be analyzed as a standalone $33.7 million investment business. The September 4, 2026 Form D/A reports $33.7 million cumulatively sold to 20 investors, an indefinite Rule 506(b) offering, Section 3(c)(7) status and a surprisingly low reported $1,000 minimum. Concentric Capital GP LLC is the general partner and Seth Turkeltaub is the central executive and promoter. The stronger structural evidence comes from Form ADV: Concentric identifies this domestic partnership together with Cayman-based Concentric Capital Partners Offshore Ltd as feeder funds that invest substantially all of their assets into Concentric Capital Master Fund LP, where the actual investment activity occurs. Latest 2026 adviser data show approximately $3.105 billion of regulatory assets under management across nine accounts and approximately $1.102 billion of private-fund gross assets across four private funds, while the domestic feeder itself reports gross assets of about $58.7 million. Those measures explain why the $33.7 million Form D subscription total is only one narrow capital-formation number and must not be treated as Concentric's firmwide AUM or master-fund NAV.
Concentric Capital Strategies Fund, LP · CIK 0001946307Read article →